IL164796A0 - Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing themand their use - Google Patents

Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing themand their use

Info

Publication number
IL164796A0
IL164796A0 IL16479603A IL16479603A IL164796A0 IL 164796 A0 IL164796 A0 IL 164796A0 IL 16479603 A IL16479603 A IL 16479603A IL 16479603 A IL16479603 A IL 16479603A IL 164796 A0 IL164796 A0 IL 164796A0
Authority
IL
Israel
Prior art keywords
preparation
themand
pharmaceutical compositions
compositions containing
benzothiazole derivatives
Prior art date
Application number
IL16479603A
Other languages
English (en)
Original Assignee
Applied Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Res filed Critical Applied Res
Publication of IL164796A0 publication Critical patent/IL164796A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16479603A 2002-04-25 2003-04-25 Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing themand their use IL164796A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02100417 2002-04-25
PCT/EP2003/004323 WO2003091249A1 (fr) 2002-04-25 2003-04-25 Piperazine benzothiazoles utilises comme agents pour le traitement de troubles ischemiques cerebraux ou de troubles du systeme nerveux central (snc)

Publications (1)

Publication Number Publication Date
IL164796A0 true IL164796A0 (en) 2005-12-18

Family

ID=29265991

Family Applications (2)

Application Number Title Priority Date Filing Date
IL164796A IL164796A (en) 2002-04-25 2003-04-25 Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing them and their use
IL16479603A IL164796A0 (en) 2002-04-25 2003-04-25 Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing themand their use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL164796A IL164796A (en) 2002-04-25 2003-04-25 Piperazine benzothiazole derivatives, their preparation, pharmaceutical compositions containing them and their use

Country Status (23)

Country Link
US (1) US7314878B2 (fr)
EP (1) EP1501828B1 (fr)
JP (1) JP4523289B2 (fr)
KR (1) KR100948469B1 (fr)
CN (1) CN1310911C (fr)
AT (1) ATE383356T1 (fr)
AU (1) AU2003233067B2 (fr)
BR (1) BRPI0309594A8 (fr)
CA (1) CA2481763C (fr)
CY (1) CY1107204T1 (fr)
DE (1) DE60318567T2 (fr)
DK (1) DK1501828T3 (fr)
EA (1) EA009682B1 (fr)
ES (1) ES2297165T3 (fr)
HK (1) HK1075664A1 (fr)
IL (2) IL164796A (fr)
MX (1) MXPA04010474A (fr)
PT (1) PT1501828E (fr)
RS (1) RS51407B (fr)
SI (1) SI1501828T1 (fr)
UA (1) UA78035C2 (fr)
WO (1) WO2003091249A1 (fr)
ZA (1) ZA200408023B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78035C2 (en) 2002-04-25 2007-02-15 Applied Research Systems Piperazine benzothiazole for treatment of cerebral ischemic disorders or cns disorders
CA2534314C (fr) * 2003-09-12 2012-11-13 Applied Research Systems Ars Holding N.V. Derives de benzothiazole pour le traitement du diabete
WO2005118543A1 (fr) * 2004-06-03 2005-12-15 Ono Pharmaceutical Co., Ltd. Inhibiteur des kinases et utilisation de cet inhibiteur
US7838522B2 (en) 2004-11-17 2010-11-23 Ares Trading S.A. Benzothiazole formulations and use thereof
EA011614B1 (ru) * 2004-11-17 2009-04-28 Арес Трейдинг С.А. Препараты бензотиазола и их применение
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 ｊｎｋ 억제제
BRPI0613042A2 (pt) * 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
WO2008125518A2 (fr) * 2007-04-17 2008-10-23 Merck Serono S.A. Procédé de préparation de pipérazine benzothiazoles
CN102015689B (zh) * 2008-05-16 2014-01-08 霍夫曼-拉罗奇有限公司 Jnk的抑制剂
KR101800916B1 (ko) * 2010-06-04 2017-11-23 에프. 호프만-라 로슈 아게 Jnk 억제제로서 유용한 2-아미노-피리미딘 유도체
US8471027B2 (en) * 2011-04-06 2013-06-25 Hoffmann-La Roche Inc. Adamantyl compounds
WO2014114186A1 (fr) * 2013-01-24 2014-07-31 山东亨利医药科技有限责任公司 Inhibiteurs de la jnk

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4153574B2 (ja) 1997-09-10 2008-09-24 トーアエイヨー株式会社 新規なピペリジン誘導体、その製造法およびそれを含有する循環器官用剤
EP1110957A1 (fr) * 1999-12-24 2001-06-27 Applied Research Systems ARS Holding N.V. Dérivés de benzazole et leur utilisation comme modulateurs de JNK
EP1193256A1 (fr) 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Derivés de benzénesulphonamide pharmaceutiquemant actifs comme inhibiteurs de protéines JNK
UA78035C2 (en) 2002-04-25 2007-02-15 Applied Research Systems Piperazine benzothiazole for treatment of cerebral ischemic disorders or cns disorders

Also Published As

Publication number Publication date
UA78035C2 (en) 2007-02-15
HK1075664A1 (en) 2005-12-23
US20050261304A1 (en) 2005-11-24
DK1501828T3 (da) 2008-03-10
CA2481763C (fr) 2011-06-14
CY1107204T1 (el) 2012-11-21
AU2003233067A1 (en) 2003-11-10
SI1501828T1 (sl) 2008-04-30
RS51407B (en) 2011-02-28
EA200401423A1 (ru) 2005-04-28
EA009682B1 (ru) 2008-02-28
AU2003233067B2 (en) 2009-01-08
ES2297165T3 (es) 2008-05-01
MXPA04010474A (es) 2004-12-13
JP2006504631A (ja) 2006-02-09
BRPI0309594A2 (pt) 2016-11-16
KR100948469B1 (ko) 2010-03-17
BRPI0309594A8 (pt) 2017-04-11
EP1501828A1 (fr) 2005-02-02
WO2003091249A1 (fr) 2003-11-06
RS92804A (en) 2006-12-15
EP1501828B1 (fr) 2008-01-09
PT1501828E (pt) 2008-02-11
CA2481763A1 (fr) 2003-11-06
CN1662528A (zh) 2005-08-31
ZA200408023B (en) 2005-11-30
CN1310911C (zh) 2007-04-18
DE60318567D1 (de) 2008-02-21
US7314878B2 (en) 2008-01-01
DE60318567T2 (de) 2009-02-19
JP4523289B2 (ja) 2010-08-11
ATE383356T1 (de) 2008-01-15
IL164796A (en) 2013-02-28
KR20040104572A (ko) 2004-12-10

Similar Documents

Publication Publication Date Title
HK1075664A1 (en) Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
EP1562897A4 (fr) Inhibiteurs de beta-secretase phenylcarboxamide utilises dans le traitement de la maladie d'alzheimer
EP1673078A4 (fr) Inhibiteurs de type benzylether et benzylamino de beta-secretase pour le traitement de la maladie d'alzheimer
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
AU2002344951A1 (en) Substituted piperazine and diazepanes as histamine h3 receptor agonists
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
CY1113306T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
PL1789398T3 (pl) Pochodne 2-amino-chinazoliny użyteczne jako inhibitory ß-sekretazy (BACE)
HUP0303363A2 (hu) Kináz-inhibitor hatású heterociklusos vegyületek alkalmazása gyógyszerkészítmények előállítására
NO20050701L (no) 4-pyrrolidino-fenyl-benzyleter derivater
NO20060278L (no) Piperazinderivater og fremgangsmater for anvendelse
ATE524169T1 (de) Therapeutische strategien für die prävention und behandlung der alzeheimer-krankheit
NO20081843L (no) Farmasoytisk sammensetning for forbedret kognitiv funksjon
NO20063137L (no) Tricykliske indolhydroksyetylaminderivater og deres anvendelse i behandlingen av Alzheimers sykdom
SE0403006D0 (sv) New compounds
IL164212A0 (en) Thiazolidine carboxamide derivatives, their preparation and pharmaceutical compositions containing them
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
IL163026A (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
WO2003070728A3 (fr) Composes aryle substitues permettant de traiter une maladie
TW200612940A (en) Substituted tetrahydroisoquinolines as mmp inhibitors, process for their preparation and their use as medicament
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.